A Study of MDX-1106 to Treat Patients With Hepatitis C Infection
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study examines the safety, tolerability, and immunogenicity of a single dose of MDX-1106
in patients with active hepatitis C genotype 1 or mixed hepatitis C genotype infection.